News

Public · Published

Super Micro stock plunges, analyst sees 140% upside

Super Micro Computer shares lost almost a third of their value in a month amid concerns about profitability and reports of a suspected Justice Department probe into alleged hardware diversion to China. No reported investigation has found corporate misconduct. Raymond James analyst Simon Leopold kept a $65 price target.

Published:

Updated:

What happened

Super Micro Computer shares lost almost a third of their value in a month amid concerns about profitability and reports of a suspected Justice Department probe into alleged hardware diversion to China. No reported investigation has found corporate misconduct. Raymond James analyst Simon Leopold kept a $65 price target.

Confirmed

Global impact / market context

Rapid sales growth has not translated into stronger profitability: gross margin, the share of sales left after direct costs, fell as lower-profit AI installations grew. Negative free cash flow means the business used more cash than it generated, while heavy reliance on one customer adds revenue risk.

Analyst inference

The analyst’s $65 target is much higher than the quoted share price, but the article also gives a lower $43.60 consensus target. These are analyst estimates, not guaranteed outcomes; the investigation reports, falling profitability and cash outflow complicate the optimistic growth case.

Analyst inference

What to watch

  1. Check whether Super Micro sustains sales growth and improves gross margin in later quarterly results; stronger revenue without better profit per sale may not resolve profitability concerns. Analyst inference
  2. Watch for developments in the reported Justice Department investigation and any findings about alleged hardware diversion; the article says no reported investigation has found corporate misconduct. Analyst inference
  3. Track free cash flow, meaning cash generated after business spending, and customer concentration; the reported negative $481 million and one customer’s over-44% sales share expose funding and revenue risks. Analyst inference

Evidence